These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 18604514)
1. Loss of imprinting of IGF2 and H19, loss of heterozygosity of IGF2R and CTCF, and Helicobacter pylori infection in laryngeal squamous cell carcinoma. Grbesa I; Marinkovic M; Ivkic M; Kruslin B; Novak-Kujundzic R; Pegan B; Bogdanovic O; Bedekovic V; Gall-Troselj K J Mol Med (Berl); 2008 Sep; 86(9):1057-66. PubMed ID: 18604514 [TBL] [Abstract][Full Text] [Related]
2. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801 [TBL] [Abstract][Full Text] [Related]
3. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues. Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026 [TBL] [Abstract][Full Text] [Related]
4. A loss of insulin-like growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells. Fu VX; Schwarze SR; Kenowski ML; Leblanc S; Svaren J; Jarrard DF J Biol Chem; 2004 Dec; 279(50):52218-26. PubMed ID: 15471867 [TBL] [Abstract][Full Text] [Related]
5. Mutation of a single CTCF target site within the H19 imprinting control region leads to loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance. Pant V; Kurukuti S; Pugacheva E; Shamsuddin S; Mariano P; Renkawitz R; Klenova E; Lobanenkov V; Ohlsson R Mol Cell Biol; 2004 Apr; 24(8):3497-504. PubMed ID: 15060168 [TBL] [Abstract][Full Text] [Related]
6. CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. Kurukuti S; Tiwari VK; Tavoosidana G; Pugacheva E; Murrell A; Zhao Z; Lobanenkov V; Reik W; Ohlsson R Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10684-9. PubMed ID: 16815976 [TBL] [Abstract][Full Text] [Related]
7. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas. Rainho CA; Kowalski LP; Rogatto SR Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232 [TBL] [Abstract][Full Text] [Related]
8. Quantitative allele-specific expression and DNA methylation analysis of H19, IGF2 and IGF2R in the human placenta across gestation reveals H19 imprinting plasticity. Buckberry S; Bianco-Miotto T; Hiendleder S; Roberts CT PLoS One; 2012; 7(12):e51210. PubMed ID: 23227253 [TBL] [Abstract][Full Text] [Related]
9. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II. Kim SJ; Park SE; Lee C; Lee SY; Jo JH; Kim JM; Oh YK Biochim Biophys Acta; 2002 Apr; 1586(3):307-15. PubMed ID: 11997082 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites. Yang Y; Hu JF; Ulaner GA; Li T; Yao X; Vu TH; Hoffman AR J Cell Biochem; 2003 Dec; 90(5):1038-55. PubMed ID: 14624463 [TBL] [Abstract][Full Text] [Related]
11. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220 [TBL] [Abstract][Full Text] [Related]
12. Relationship of porcine IGF2 imprinting status to DNA methylation at the H19 DMD and the IGF2 DMRs 1 and 2. Braunschweig MH; Owczarek-Lipska M; Stahlberger-Saitbekova N BMC Genet; 2011 May; 12():47. PubMed ID: 21575277 [TBL] [Abstract][Full Text] [Related]
13. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628 [TBL] [Abstract][Full Text] [Related]
14. Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma. Grbesa I; Ivkic M; Pegan B; Gall-Troselj K Cancer Lett; 2006 Jul; 238(2):224-9. PubMed ID: 16111804 [TBL] [Abstract][Full Text] [Related]
15. Prohibitin 1 Regulates the H19-Igf2 Axis and Proliferation in Hepatocytes. Ramani K; Mavila N; Ko KS; Mato JM; Lu SC J Biol Chem; 2016 Nov; 291(46):24148-24159. PubMed ID: 27687727 [TBL] [Abstract][Full Text] [Related]
16. Role of CTCF binding sites in the Igf2/H19 imprinting control region. Szabó PE; Tang SH; Silva FJ; Tsark WM; Mann JR Mol Cell Biol; 2004 Jun; 24(11):4791-800. PubMed ID: 15143173 [TBL] [Abstract][Full Text] [Related]
17. IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation-sensitive single-nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell development. Sievers S; Alemazkour K; Zahn S; Perlman EJ; Gillis AJ; Looijenga LH; Göbel U; Schneider DT Genes Chromosomes Cancer; 2005 Nov; 44(3):256-64. PubMed ID: 16001432 [TBL] [Abstract][Full Text] [Related]
18. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321 [TBL] [Abstract][Full Text] [Related]
19. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate. Fu VX; Dobosy JR; Desotelle JA; Almassi N; Ewald JA; Srinivasan R; Berres M; Svaren J; Weindruch R; Jarrard DF Cancer Res; 2008 Aug; 68(16):6797-802. PubMed ID: 18701505 [TBL] [Abstract][Full Text] [Related]
20. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]